Abstract
Background
Nonvariceal upper gastrointestinal bleeding (UGB) has important morbidity and mortality. Predicting high-risk patients for mortality and rebleeding is necessary for a treatment plan. In the present study, we aimed to define the epidemiological and etiological characteristics of patients presenting with nonvariceal UGB and to observe mortality and morbidity rates. We also aimed to compare Rockall and Glasgow-Blatchford scoring systems in predicting rebleeding and mortality.
Methods
Subjects presenting with nonvariceal UGB over a 3-year period were included. Demographic characteristics, symptoms, and signs on physical examination, laboratory data, endoscopic signs and diagnosis, interventions during hospitalization and follow-up period were recorded. Glasgow-Blatchford and Rockall scores were calculated for every participant at the first day of the admission.
Results
A total of 709 patients were enrolled in the study. A total of 490 of them (69.1%) were men. The mean age of the women and men was 60.7±1.2 and 58.6± 0.7 years, respectively. Melena was the most common presenting symptom. Duodenal ulcer (31%), gastric ulcer (20.7%), and erosive disease (17.6%) were the most common causes of bleeding. History of use of aspirin and/or nonsteroidal anti-inflammatory drug use were present in 63.7% of the subjects. All patients were followed up for 30th-day mortality. Overall, rebleeding and mortality rates were 11% and 7%, respectively. A Rockall score greater than 6 was the most important predictor of mortality (odds ratio:39.1) and rebleeding (odds ratio:4.7).
Conclusion
Nonvariceal UGB patients with a Rockall score greater than 6 should undergo aggressive endoscopic treatment and inpatient care.
Similar content being viewed by others
References
Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995;311:222–6.
Pfau PR, Cooper GS, Carlson MD, et al. Success and shortcomings of a clinical care pathway in the management of acute nonvariceal upper gastrointestinal bleeding. Am J Gastroenterol. 2004;99:425–31.
Rivkin K, Lyakhovetskiy A. Treatment of nonvariceal upper gastrointestinal bleeding. Am J Health Syst Pharm. 2005;62:1159–70.
Ozen E, Oruc N, Ozutemiz O, et al. Review of 412 patients with non-variceal upper gastrointestinal bleeding. Akademik Gastroenteroloji Dergisi. 2007;6:62–7.
Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–21.
Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–21.
Forrest JH, Finlayson N, Shearman D. Endoscopy in gastrointestinal bleeding. Lancet. 1974;304:394–7.
Yavorski RT, Wong RK, Maydonovitch C, et al. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 1995;90:568–73.
Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238–46.
Sezgin O, Altintaş E, Tombak A. Effects of seasonal variations on acute upper gastrointestinal bleeding and its etiology. Turk J Gastroenterol. 2007;18:172–6.
Skok P, Skok M. Upper gastrointestinal tract hemorrhage and nonsteroidal-antiinflammatory drugs (NSAIDs)-a 5-year prospective study. Zdravniski Vestnik. 2002;71:153–6.
Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1995;90:206–10.
Bini E, Unger J, Cohen J. Predictors of gastrointestinal hemorrhage in 893 patients with benign-appearing gastric ulcers. Gastroenterology. 1998;114:A5.
Çoban E, Süleymanlar İ, Ertuğrul C. Gastrointestinal sistem kanamalar: 177 olgunun değerlendirilmesi. Turk J Gastroenterol. 1997;8:335.
Bayır A, Okumuş M, Köstekçi ŞK, Şahin TK. Üst GİS kanamalarında risk faktörlerinin prognoz üzerine etkisi. Genel Tıp Derg. 2003;13:157–61.
Shennak MM. Etiology of upper gastrointestinal bleeding in Jordanian patients: A prospective study. Ann Saudi Med. 1995;15:54–9.
Khan YI, Gunaratnam NT. Acute nonvariceal bleeding. In: Ginsberg GG, ed. Clinical gastrointestinal Endoscopy. 1st ed. USA: Elsevier Saunders; 2005. p. 147–63.
Barkun AN, Chiba N, Enns R, et al. Use of a national endoscopic database to determine the adoption of emerging pharmacological and endoscopic technologies in the every day care of patients with upper GI bleeding: the RUGBE initiative. Am J Gastroenterol. 2001;9:S261.
Vreeburg EM, Snel P, de Bruijne JW, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol. 1997;92:236–43.
Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol. 1997;92:924–8.
Skok P. The epidemiology of hemorrhage from the upper gastrointestinal tract in the mid-nineties--has anything changed? Hepatogastroenterology. 1998;45:2228–33.
Llach J, Elizalde JI, Guevara MC, et al. Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial. Gastrointest Endosc. 2001;54:679–81.
Esrailian E, Gralnek IM. Nonvariceal upper gastrointestinal bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am. 2005;34:589–605.
Savides T, Jensen D, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy. 1996;28:244–8.
Katschinski B, Logan R, Davies J, et al. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci. 1994;39:706–12.
Vreeburg EM, Terwee CB, Snel P, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut. 1999;44:331–5.
Rockall TA, Logan RF, Devlin HB, Northfield TC. Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet. 1995;346:346–50.
Lewis JD, Bilker WB, Brensinger C, et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol. 2002;97:2540–9.
Gürel S, İmadoğlu O. Varis ve malignite dışı üst gastrointestinal sistem kanamalarının değerlendirilmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2004;30:87–91.
Guglielmi A, Ruzzenente A, Sandri M, et al. Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy. 2002;34:778–86.
Branicki FJ, Coleman SY, Pritchett CJ, et al. Emergency surgical treatment for nonvariceal bleeding of the upper part of the gastrointestinal tract. Surg Gynecol Obstet. 1991;172:113–20.
Church NI, Palmer KR. Relevance of the Rockall score in patients undergoing endoscopic therapy for peptic ulcer haemorrhage. Eur J Gastroenterol Hepatol. 2001;13:1149–52.
Bessa X, O'Callaghan E, Ballesté B, et al. Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding. Dig Liver Dis. 2006;38:12–7.
Sanders DS, Carter MJ, Goodchap RJ, et al. Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol. 2002;97:630–5.
Stanley AJ, Dalton HR, Blatchford O, et al. Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage. Aliment Pharmacol Ther. 2011;34:470–5.
Chandra S, Hess EP, Agarwal D, et al. External validation of the Glasgow-Blatchford Bleeding Score and the Rockall Score in the US setting. Am J Emerg Med. 2012;30:673–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
GA, MU, TB, RA, FG, and AB declare no competing interests.
Ethics statement
The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.
Ethical approval
The study was approved by the Ethics Committee of the Ondokuz Mayis University, Faculty of Medicine, and complied with the Declaration of Helsinki.
Disclaimer
The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Aktas, G., Ustaoglu, M., Bakir, T. et al. Analysis of the patients with nonvariceal upper gastrointestinal bleeding and comparison of Rockall and Glasgow-Blatchford scores. Indian J Gastroenterol 41, 576–582 (2022). https://doi.org/10.1007/s12664-022-01290-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-022-01290-z